Cholangiocarcinoma.


Journal

Pathologica
ISSN: 1591-951X
Titre abrégé: Pathologica
Pays: Italy
ID NLM: 0401123

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 04 01 2021
accepted: 04 01 2021
entrez: 23 7 2021
pubmed: 24 7 2021
medline: 29 10 2021
Statut: ppublish

Résumé

Liver cancer represents the third leading cause of cancer-related death worldwide. Cholangiocarcinoma (CCA) is the second most common type of liver cancer after hepatocellular carcinoma, accounting for 10-15% of all primary liver malignancies. Both the incidence and mortality of CCA have been steadily increasing during the last decade. Moreover, most CCAs are diagnosed at an advanced stage, when therapeutic options are very limited. CCA may arise from any tract of the biliary system and it is classified into intrahepatic, perihilar, and distal CCA, according to the anatomical site of origin. This topographical classification also reflects distinct genetic and histological features, risk factors, and clinical outcomes. This review focuses on histopathology of CCA, its differential diagnoses, and its diagnostic pitfalls.

Identifiants

pubmed: 34294934
doi: 10.32074/1591-951X-252
pmc: PMC8299326
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

158-169

Informations de copyright

Copyright © 2021 Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.

Références

Am J Surg Pathol. 2018 Apr;42(4):512-521
pubmed: 29309301
Hepatology. 2021 Jan;73 Suppl 1:62-74
pubmed: 32304327
Diagn Pathol. 2014 Jul 01;9:131
pubmed: 24986479
Cancer Imaging. 2010 Oct 04;10 Spec no A:S142-50
pubmed: 20880773
World J Surg. 2007 Oct;31(10):2016-22
pubmed: 17687597
Hum Pathol. 2013 Jul;44(7):1241-50
pubmed: 23332923
Am J Surg Pathol. 2001 Oct;25(10):1297-303
pubmed: 11688465
APMIS. 2018 Jun;126(6):494-500
pubmed: 29924451
Am J Surg Pathol. 2010 Aug;34(8):1147-54
pubmed: 20661013
Nat Genet. 2015 Sep;47(9):1003-10
pubmed: 26258846
Cancer Imaging. 2014 Apr 22;14:14
pubmed: 25608662
Nat Rev Gastroenterol Hepatol. 2016 May;13(5):261-80
pubmed: 27095655
Clin Mol Hepatol. 2019 Mar;25(1):12-20
pubmed: 30300991
Semin Liver Dis. 2011 Feb;31(1):104-10
pubmed: 21344355
Nat Commun. 2014 Dec 15;5:5696
pubmed: 25526346
J Hepatol. 2014 Jun;60(6):1268-89
pubmed: 24681130
J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):94-100
pubmed: 25181580
Hepatology. 2021 Jan;73 Suppl 1:75-85
pubmed: 32500550
Curr Opin Gastroenterol. 2020 Mar;36(2):57-62
pubmed: 31895230
Liver Int. 2019 May;39 Suppl 1:7-18
pubmed: 30882996
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):277-93
pubmed: 25966428
Hum Pathol. 2016 Nov;57:61-67
pubmed: 27396933
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588
pubmed: 32606456
Hum Pathol. 2020 May;99:80-87
pubmed: 32272125
Oncol Rep. 2014 Oct;32(4):1355-61
pubmed: 25109922
Abdom Radiol (NY). 2020 Nov;45(11):3662-3680
pubmed: 32417933
J Hepatol. 2020 Aug;73(2):315-327
pubmed: 32173382
J Clin Pathol. 2002 Sep;55(9):719
pubmed: 12195010
Gastroenterology. 2013 Apr;144(4):829-40
pubmed: 23295441
Nat Rev Clin Oncol. 2018 Feb;15(2):95-111
pubmed: 28994423
JHEP Rep. 2019 Jul 10;1(4):297-311
pubmed: 32039381
World J Gastroenterol. 2013 Jun 14;19(22):3524-7
pubmed: 23801851
J Hepatol. 2006 Oct;45(4):568-74
pubmed: 16879890
Histopathology. 2018 Sep;73(3):369-385
pubmed: 29573451
Pathol Oncol Res. 2020 Jan;26(1):3-15
pubmed: 30448973
Cancer. 1999 Feb 1;85(3):562-82
pubmed: 10091730
Hum Pathol. 2012 Dec;43(12):2292-8
pubmed: 22795356
J Hepatol. 2018 May;68(5):959-969
pubmed: 29360550
Ann Diagn Pathol. 2019 Feb;38:126-137
pubmed: 30597357
Am J Surg Pathol. 2012 Nov;36(11):1629-35
pubmed: 23073321
Hepatology. 2021 Jan;73 Suppl 1:115-127
pubmed: 32045030
Cells. 2020 Feb 13;9(2):
pubmed: 32069926
Hum Pathol. 2017 Apr;62:232-241
pubmed: 28232156
Dig Liver Dis. 2020 Dec;52(12):1430-1442
pubmed: 32952071
World J Gastroenterol. 2019 Aug 21;25(31):4343-4359
pubmed: 31496617
J Hepatol. 2017 May;66(5):952-961
pubmed: 28126467
Ann Diagn Pathol. 2020 Dec;49:151589
pubmed: 32947230
Am J Surg Pathol. 2014 Mar;38(3):364-9
pubmed: 24487593
Hepatobiliary Surg Nutr. 2017 Apr;6(2):101-104
pubmed: 28503557
Dig Liver Dis. 2020 Nov;52(11):1282-1293
pubmed: 32893173
Pathol Res Pract. 2019 Jul;215(7):152430
pubmed: 31101576
Breast Cancer Res Treat. 2018 May;169(1):25-32
pubmed: 29340880
Mod Pathol. 2013 Jun;26(6):782-91
pubmed: 23348905
Cancer J. 2009 May-Jun;15(3):257-61
pubmed: 19556914

Auteurs

Samantha Sarcognato (S)

Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.

Diana Sacchi (D)

Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.

Matteo Fassan (M)

Department of Medicine - DIMED, University of Padova, Padova, Italy.

Luca Fabris (L)

Department of Molecular Medicine - DMM, University of Padova, Padova, Italy.

Massimiliano Cadamuro (M)

Department of Molecular Medicine - DMM, University of Padova, Padova, Italy.

Giacomo Zanus (G)

4th Surgery Unit, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.
Department of Surgery, Oncology and Gastroenterology - DISCOG, University of Padova, Padova, Italy.

Ivana Cataldo (I)

Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.

Paola Capelli (P)

Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy.

Francesca Baciorri (F)

Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.

Matilde Cacciatore (M)

Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.

Maria Guido (M)

Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.
Department of Medicine - DIMED, University of Padova, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH